As of 3:59pm ET
| +0.13 / +2.66%|
The 8 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 9.75, with a high estimate of 13.75 and a low estimate of 8.00. The median estimate represents a +94.61% increase from the last price of 5.01.
The current consensus among 8 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.